EAST ST. LOUIS, Ill. - The federal judge overseeing the Pradaxa multidistrict litigation on Jan. 29 granted in full a plaintiffs' motion to remove the confidentiality designations by defendant Boehringer Ingelheim (BI) on 85 documents (In Re: Pradaxa [Dabigatran Etexilate] Products Liability Litigation, MDL Docket No. 2395, No. 3:12-md-2385, S.D. Ill, E. Div.).